Close
(0) items
You have no items in your shopping cart.
All Categories
    Filters
    Preferences
    Search

    Bad Moves: How decision making goes wrong, and the ethics of smart drugs

    €21.25
    How do our brains make choices? How do factors such as Alzheimer's or depression impair decision-making? Presenting the latest research on 'hot' and 'cold' decision-making, Barbara Sahakian and Jamie Nicole LaBuzetta look at the therapeutic smart drugs now available, and raise concerns about their unregulated use to enhance mental performance.
    ISBN: 9780199668472
    AuthorSahakian, Barbara (University of Cambrid
    SubAuthor1LaBuzetta, Jamie Nicole (University of C
    Pub Date25/04/2013
    BindingHardback
    Pages192
    AvailabilityCurrently out of stock. If available, delivery is usually 5-10 working days.
    Availability: Out of Stock

    Making decisions is such a regular activity that it is mostly taken for granted. However, damage or abnormality in the areas of the brain involved in decision-making can severely affect personality and the ability to manage even simple tasks.

    Here, Barbara Sahakian and Jamie Nicole LaBuzetta discuss the process of normal decision making - our strategies for making decisions, biases that affect us, and influential factors - and then describe the abnormal patterns found in patients with conditions such as severe depression, Alzheimer's, and accidental brain damage.

    Using striking examples and case studies from their own research to show the impact of abnormal decision making, they introduce the concept of 'hot' and 'cold' decision making based on the level of emotions involved, showing that in various psychiatric conditions extreme emotions alter the pattern of decision making.

    Looking at the ways in which the brain can be manipulated to improve cognitive function in these patients, they consider the use of 'smart drugs' that alleviate these problems. The realization that smart drugs can improve cognitive abilities in healthy people has led to growing general use, with drugs easily available via the Internet. They raise ethical questions about the availability of these drugs for cognitive enhancement, in the hope of informing public debate about an increasingly
    important issue.